KALAMAZOO, MI-The FDA has informed Stryker Corp. that it has sufficiently addressed issues raised in a 2007 warning letter. Stryker received the letter regarding compliance with certain quality system requirements at its reconstructive implant manufacturing facility in Mahwah, NJ, in 2007. MORE